A detailed history of Goodman Advisory Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Goodman Advisory Group, LLC holds 614 shares of PFE stock, worth $16,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
614
Previous 614 -0.0%
Holding current value
$16,418
Previous $17,000 -0.0%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $659,521 - $856,645
-25,240 Reduced 97.63%
614 $17,000
Q3 2023

Oct 11, 2023

SELL
$32.09 - $37.51 $7.34 Million - $8.57 Million
-228,592 Reduced 89.84%
25,854 $857,000
Q2 2023

Aug 11, 2023

BUY
$36.12 - $41.79 $9.17 Million - $10.6 Million
253,832 Added 41340.72%
254,446 $9.33 Million
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $28,569 - $33,874
614 New
614 $32,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Goodman Advisory Group, LLC Portfolio

Follow Goodman Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goodman Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Goodman Advisory Group, LLC with notifications on news.